Fanconi Anemia (FA) is a multi-genic disorder that results in progressive bone marrow failure and a strong predisposition to myelodysplastic syndrome and leukemia. FA proteins are involved in the cellular response to DNA damage by a largely unknown mechanism. A nuclear complex of at least 8 FA proteins is required for the monoubiquitination of FANCD2. Monoubiquitination of FANCD2 is required for resistance to the crosslinker mitomycin C. The ATR checkpoint kinase also regulates FANCD2 monoubiquitination and potentially links FANCD2 to the detection of DNA damage at the replication fork. The goal of this study is to understand the regulation and function of FANCD2 monoubiquitination, and thereby to better understand the collective role of FA proteins in promoting normal hematopoiesis. Certain FA proteins are mutated in spontaneous cancers in the general population, so these studies are also relevant to understanding how cancer develops.
The specific aims of the study are as follows: 1) Delineate mechanisms of the ATR-dependent regulation of FANCD2 monoubiquitination. How, and whether, MCM7 and Rad17, along with Rad9, cooperate to couple FANCD2 monoubiquitination to the detection of DNA damage at the replication fork will be determined. ShRNA-mediated suppression of these proteins in primary human CD34+ cells, and expression of mutants in an immortalized myeloid precursor line, will be utilized. Whether these DNA damage sensors prevent chromosomal instability and apoptosis in response to MMC will also be determined. 2) Determine whether defects in FANCD2 monoubiquitination and the assembly of FANCD2 foci results in chromosomal instability and sensitivity to MMC in CD34+ hematopoietic stem/progenitor cells. FANCD2 monoubiquitination will be inhibited by shRNA-mediated suppression of FANCA. Also, mechanisms involved in the recruitment of FANCD2 to blocked replication forks will be elucidated using real-time microscopy in cells reconstituted with EGFP- FANCD2. PROJECT NARRATIVE It is increasingly clear that alterations in some Fanconi anemia pathway proteins are involved in some spontanous cancers seen in the general population. Thus the studies described in this application may shed new light on both normal and abnormal stem cell function and on cancer formation.
|Broering, Tyler J; Alavattam, Kris G; Sadreyev, Ruslan I et al. (2014) BRCA1 establishes DNA damage signaling and pericentric heterochromatin of the X chromosome in male meiosis. J Cell Biol 205:663-75|
|Park, Jung-Young; Zhang, Fan; Andreassen, Paul R (2014) PALB2: the hub of a network of tumor suppressors involved in DNA damage responses. Biochim Biophys Acta 1846:263-75|
|Kavanaugh, Gina M; Wise-Draper, Trisha M; Morreale, Richard J et al. (2011) The human DEK oncogene regulates DNA damage response signaling and repair. Nucleic Acids Res 39:7465-76|
|Ichijima, Yosuke; Ichijima, Misako; Lou, Zhenkun et al. (2011) MDC1 directs chromosome-wide silencing of the sex chromosomes in male germ cells. Genes Dev 25:959-71|
|Hayakawa, Tomohiro; Zhang, Fan; Hayakawa, Noriyo et al. (2010) MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. J Cell Sci 123:1124-30|
|Zhang, Fan; Fan, Qiang; Ren, Keqin et al. (2010) FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses. Chromosoma 119:637-49|
|Pang, Qishen; Andreassen, Paul R (2009) Fanconi anemia proteins and endogenous stresses. Mutat Res 668:42-53|
|Fan, Qiang; Zhang, Fan; Barrett, Briana et al. (2009) A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res 37:1740-54|
|Andreassen, Paul R; Ren, Keqin (2009) Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy. Curr Cancer Drug Targets 9:101-17|
|Singh, Thiyam Ramsing; Ali, Abdullah Mahmood; Busygina, Valeria et al. (2008) BLAP18/RMI2, a novel OB-fold-containing protein, is an essential component of the Bloom helicase-double Holliday junction dissolvasome. Genes Dev 22:2856-68|